CII wants Infrastructure Status for Bulk Drug Industry India needs to overcome challenges around land acquisition, ease of doing business, environmental clearances, taxation, and R&D need to be resolved for India to become a global active pharmaceutical ingredient (API), according...
Read moreDetails












